SUBSCRIBE
SUBSCRIBE
News   FDA

Covidien Ltd Wins FDA OK For Generic Heart Image Agent

February 27, 2008 | 
1 min read
CHICAGO, Feb 27 (Reuters) - Healthcare products company Covidien said on Wednesday the U.S. Food and Drug Administration granted tentative approval for its generic imaging agent used for detecting coronary artery disease.
FDA Approvals
MORE ON THIS TOPIC
Staying ahead of your competitors. Accelerated development of the company. Innovation vision. Customized solution. Unique skills. Red paper plane and whites. 3d render
FDA
New FDA draft guidance doubles down on expediting approvals of personalized gene therapies
October 28, 2026
 · 
4 min read
 · 
Heather McKenzie
Insights
Australia’s clinical trial advantage gains ground amid U.S. uncertainty
October 26, 2026
 · 
4 min read
 · 
Jennifer C. Smith-Parker
aardvark walking in the desert
FDA
FDA uncages Aardvark’s Prader-Willi study after new data cleared safety concerns
October 23, 2026
 · 
3 min read
 · 
Tristan Manalac
Isometric arrow overcoming above wall on turquoise blue background. Challenge, success, development and solution concept. Flat design. Vector illustration, no transparency, no gradients
Immunology and inflammation
AbbVie’s skin disease drug lessens abscess burden in Phase 3 but falls below expectations
October 22, 2026
 · 
3 min read
 · 
Gabrielle Masson